FACA Committee Purpose & Justification The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format. Fiscal Year:2011 Committee Type: Other Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health Science Products and Services DOC f3709a45-a685-4471-85c8-b491905bbf26 [21406]: http://www.trade.gov/itac Department of Commerce [12]: http://www.doc.gov Sponsoring Agency Beneficiary Mr. Luis H. Arguello Jr. Vice President, DemeTech Corporation Committee Member Representative Performer Mr. Robert E. Branand Esq. Representing the Society of Chemical Manufacturers and Affiliates Committee Member Representative Performer Mr. Shawn M. Brown Vice President, State Affairs, Generic Pharmaceutical Association Committee Member Representative Performer Mr. P. Claude Burcky Divisional Vice President, Global Government Affairs and Policy, Abbott Laboratories Committee Member Representative Performer Mr. V. (Jim) M. Delisi President, Fanwood Chemical, Inc. Committee Member Representative Performer Mr. Donald E. Ellison Representing Innegrity LLC Committee Member Representative Performer Mr. Zoran I. Franicevich Manager, Global Trade Programs, The Clorox Company Committee Member Representative Performer D. Geoffrey Gamble Esq. Chief International Counsel and Director, Intl. Government Affairs, E.I. du Pont de Nemours & Company Committee Member Representative Performer Mr. Edward L. Gibbs President, North Coast Medical Equipment Inc. Committee Member Representative Performer Mr. Vijay Goradia Vinmar International, Ltd. Committee Member Representative Performer Mr. Trevor J. Gunn Ph.D. Director, International Relations, Medtronic, Inc. Committee Member Representative Performer Ms. Tine K. Hansen-Turton Chief Executive Officer, National Nursing Centers Consortium Committee Member Representative Performer Jonathan Herzog, Esq. Counsel, International Trade, St. Jude Medical, Inc. Committee Member Representative Performer Mr. Ralph F. Ives Executive Vice President, Advanced Medical Technology Association Committee Member Representative Performer Mr. Maurice J. Kerins President, Airmed Biotech, Inc. Committee Member Representative Performer Mr. Craig S. Kramer Vice President International Government Affairs, Johnson & Johnson Committee Member Representative Performer Mr. Adrian Krygsman Director, Product Registration, Troy Corporation Committee Member Representative Performer Mr. Matthew T. McGrath Esq. Legal Advisor, Representing Intermune, Inc. Committee Member Representative Performer Mr. Douglas T. Nelson Esq. Executive Vice President, Gnrl Counsel, Secretary, CropLife America Committee Member Representative Performer Ms. Tracey J. Norberg Esq. Senior VP, Environment and Resource Recovery, Rubber Manufacturers Association Committee Member Representative Performer Ms. Lisa A. Phillip President, Hybas International, LLC Committee Member Representative Performer Mr. George L. Rolofson Ph.D. Consultant in Agricultural Science and Environmental, Regulatory, and Trade Policy, Representing Gowan Company Committee Member Representative Performer Mr. Richard I. Sedlak Senior Vice President, Technical and International Affairs, The American Cleaning Institute Committee Member Representative Performer Mr. Albert C. Sutphin President, Braden Sutphin Ink Company Committee Member Representative Performer Jay T. Taylor, Esq. Vice President, International Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) Committee Member Representative Performer Mr. Max Turnipseed Esq. Representing The Dow Chemical Company Committee Member Representative Performer Harry L. Vroomen Ph.D. Vice President, Economic Services, The Fertilizer Institute Committee Member Representative Performer Mr. Thomas G. Zieser President and Chief Executive Officer, JACE Systems Committee Member Representative Performer Not Available 9fb0387c-0d9e-4dd3-9f9e-7fb0d751ccc9 Most feedback is rendered orally during meetings; when written advice is sent to the Secretary of Commerce and the USTR, or their designees, it is reviewed by the Secretary's policy staff and tasked to appropriate ITA units to prepare draft response. Commerce internal procedures require that all responses for Secretarial signature (and/or joint signature with USTR)go through a concurrence process which ensures that the appropriate level Commerce officials are seeing the advice and have an opportunity for comment. All formal responses must be cleared by the Under Secretary of Commerce for International Trade prior to the Secretary's signature, which ensures that ITAC advice is weighed and considered. 6f7b857f-1a02-49ce-873a-88c736910be0 Recommandations Not Available 64c9c019-7b01-4fdf-a921-8178694abcaa Make, Accept, Implement 334bab13-b069-49d1-97fc-46e99f2b0801 671fe250-2ccc-4053-84b7-d48517c964c7 Recommendations Made Number Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health Science Products and Services Department of Commerce Unspecified n/a 2010-10-01 2011-09-30 The average number of recommendations is 3-4 annually. 0 2010-10-01 2011-09-30 7ab3e42d-3c16-45bc-b49d-dab079667fdb Recommendations Fully Accepted Percentage Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health Science Products and Services Department of Commerce For a variety of its own reasons not applicable to the Committee, the agency may implement all/most of the recommendations, but few times recommendations are not implemented. n/a 2010-10-01 2011-09-30 The Committee's recommendations for a harmonized simplified Rules of Origin in all free trade agreements are still being considered/implemented.Recommendations on REACh, the JCCT and the Doha Round negotiations are still being considered. 50 2010-10-01 2011-09-30 dc7e4936-dde1-4a6d-999a-87934b659c2e Recommendations Partially Accepted Percentage Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health Science Products and Services Department of Commerce There are sometimes a few proposals which were not funded in their entirety, those few being scaled back from their original level of requested funding (allowable under the program). n/a 2010-10-01 2011-09-30 The Department of Commerce and USTR have carefully consulted ITAC 3 for recommendations on all trade policy negotiations. Many of the recommendations have been taken into account, with much still under negotiation. 50 2010-10-01 2011-09-30 2010-10-01 2011-09-30 2013-07-09 http://explore.data.gov/resource/datasets/c5i3-bb9j Gannon (J.) Dick gannon_dick@yahoo.com Submit error.